Background: Usually serum albumin is measured with dye-binding assay as bromocresol green (BCG) and bromocresol purple (BCP) methods. The aim of this paper was to examine the differences in albumin measurements between the Advia2400 BCG method (AlbBCG), Dimension RxL BCP (AlbBCP) and capillary zone electrophoresis (CZE).
Traditionally, serum albumin is a biomarker used to identify malnutrition in patients.
1,2 Also, it is well established that albumin levels fall in patients with inflammatory disorders and other acute or chronic diseases by suppressing synthesis, increasing catabolism and/or vascular permeability, or a combination of these processes. 1 Low serum albumin levels have been associated with higher mortality in a number of different populations, in pathways that may not Abbreviations BCG, bromocresol green; BCP, bromocresol purple; Alb BCG , albumin quantified using BCG method; Alb BCP , albumin quantified using BCP method; CZE, capillary zone electrophoresis; aCa, adjusted calcium 1 Clinical Biochemistry Laboratory, Servicio de Analisis Clinicos, Hospital Universitario Cabueñes, Asturias, Spain; 2 Facultad de Enfermeria de Gijon, Universidad de Oviedo, Asturias, Spain *To whom correspondence should be addressed. vgmoreira@yahoo.es result solely from malnutrition. For this reason, serum albumin is also often used as a prognostic indicator of disease progression. 3 There are several causes of hypoalbuminemia and several pathologic manifestations in which it can appear. For example, decrease in liver function, as in liver cirrhosis, produces a decrease in the concentration of albumin, which can be marked and associated with limb edema and ascites. Also, renal disease with loss of albumin from the kidneys may occur with decreased serum albumin. Any type of chronic disease with nutritional compromise can be associated with hypoalbuminemia, such as neoplasms, heart failure, and intestinal diseases. Malabsorption or diseases that prevent adequate absorption of nutrients by the digestive tract are associated with malnutrition and hypoalbuminemia. No specific diseases associated with elevated albumin 356 Lab Medicine 2018;49;355-361 DOI: 10.1093/labmed/lmy020 levels have been described in the literature, to our knowledge, so such findings on routine tests do not indicate abnormality.
The most specific method for albumin measurement is immunonephelometry; however, this method is usually reserved for cerebrospinal fluid, which has lower albumin concentrations. Although nephelometry is arguably the most selective and therefore the most likely method to accurately quantify serum albumin, the relative expense and the requirement for additional analytical equipment often make nephelometry impractical. Currently, most laboratories use dye-binding methods. In clinical practice, albumin is measured using automated techniques that use 1 of 2 dye-binding assays: bromocresol green (BCG) and bromocresol purple (BCP). 4, 5 Although BCG remains the dominant methodology, a significant number of laboratories use BCP. In our country, Spain, BCG is the most widely used method for serum albumin measurement (55% of laboratories), followed by BCP (17%) and immunonephelometry (13%). 6 The BCP method is performed using the Dimension RxL analyzer (Siemens Healthcare GmbH) in our emergency laboratory, and the BCG method is performed using the ADVIA 2400 analyzer (Siemens Healthcare GmbH) in our routine laboratory. When managing a patient with serial results from the same laboratory, which albumin assay is used may be of little importance. However, when the absolute value of the serum albumin matters, understanding the methodology used and the ability to convert between methods is helpful.
In our hospital, it is possible that consecutive serum specimens for an individual patient will be measured by different albumin methods. For this reason, our goal was to quantify the extent of any discrepancies. This study aimed to examine differences among albumin measurements quantified using the BCG method (Alb BCG ) via the ADVIA 2400 instrument, albumin measurement quantified using the BCP method (Alb BCP ) via the Dimension RxL instrument, and serum proteinogram values via capillary zone electrophoresis (CZE).
Concentrations of calcium are affected by albumin. Calcemia is closely regulated, with total calcium values between 2.2 and 2.6 mmol per L (9.0-10.5 mg/dL) and ionized calcium between 1.1 and 1.4 mmol per L (4.5-5.6 mg/ dL). Approximately 40% of serum calcium is bound to albumin, whereas only free ionized calcium is biologically active in extracellular fluids. 7 The amount of total calcium varies with the level of albumin, a protein that attaches to calcium. The biological effect of calcium is determined by ionized calcium, rather than total calcium, and this effect does not vary with the level of albumin.
The relationship between ionized calcium and plasma pH is reciprocal (the increase in pH decreases the percentage of Ca++ ionization). Patients with alkalosis, for example, may show signs of hypocalcemia despite a normal level of total calcium. Changes in albumin will affect total serum calcium without changing the free calcium level. Hypocalcemia is frequently encountered in critically ill hospitalized patients.
The most accurate measure of true hypocalcaemia is the ionized calcium level.
In many hospitals like ours, there are separate emergency and routine laboratories. Most emergency laboratories have blood gas analyzers that provide direct measurement of ionized calcium. However, routine measurement of ionized calcium (criterion standard) or total calcium by indirect potentiometry or atomic absortion spectrophotometry (specific methods) is impractical. The total calcium that most self-analyzers measure is affected by albumin concentrations. To avoid this problem, the albumin-adjusted total calcium calculation known as adjusted calcium (aCa) or corrected calcium is usually used. The calcium result is corrected according to a formula that provides an estimated level of calcium if the albumin level were normal (estimated value of 40 g/L albumin). Also, we have evaluated the impact of the albumin method in calculating aCa concentrations.
Materials and Methods
We analyzed the albumin levels of 165 serum specimens using the BCG method on an Advia 2400 instrument and ran these specimens in a parallel fashion on a Dimension RxL analyzer (Siemens Healthcare GmbH) using the BCP method. All specimens included in the study had clinician requests for PCR, calcium, and serum protein electrophoresis. We used CZE results, as performed on a Capillarys 2 instrument (Sebia), to estimate different protein fractions. No monoclonal component was detected.
We collected results for electrophoretic protein fractions (albumin, α1, α2, β, and γ) as percentages of the total protein. The total protein concentration was measured using the Biuret method on the ADVIA 2400 instrument; this value was used to calculate all the protein fractions in g per L.
The calcium concentration was corrected for the albumin level using the formula aCa = total calcium + 0. Data are presented as mean (SD) or percentage, as appropriate. We determined significant differences between the 2 groups via Student paired t-testing and among several groups using analysis of variance (ANOVA), followed by posthoc Newman-Keuls testing using MedCalc statistical software, version 12.2.1 (MedCalc software bvba). The level of statistical significance was set at P <.05. Passing-Bablok regression, Bland-Altman plots, and Pearson correlation were used to examine the relationship between albumin levels, as measured by BCG and BCP methods.
Results
The correlation between BCP and BCG was 0.951 (P <.001), but the mean difference was large: 6. The results of Bland-Altman analysis showed positive bias for BCG albumin compared to CZE (mean, 3.54 g/L; 95% CI, 2.98-4.09). However, we observed good correlation between albumin as measured by CZE and BCP results, with a mean difference of less than 1 g per L (mean, 0.97 g/L; 95% CI, 0.56-1.38).
The Bland-Altman plots showed that BCP and BCG albumin measurements had greater bias at lower albumin concentrations ( Figure 1) . For the normal concentration group (group 1: Alb BCP ≥35 g/L) and the groups with mild hypoalbuminemia (group 2: Alb BCP 30-35 g/L), moderate hypoalbuminemia (group 3: Alb BCP 20-29 g/L), and severe hypoalbuminemia (group 4: Alb BCP ≤20 g/L), the mean differences in concentration were 3.07 g per L, 6.33 g per L, 7.50 g per L, and 9.92 g per L, respectively (ANOVA; P <.001). Using Newman-Keuls posthoc testing, we observed differences in group 1 vs groups 2, 3, and 4, as well as in group 4 vs groups 2 and 3 (P <.05). There was no statistically significant difference between groups 2 and 3.
Because hypoalbuminemia is usually accompanied by elevated serum globulins during inflammation or infection, we also evaluated the influence of serum globulins on discrepancies in albumin levels, as measured by the BCG and BCP methods. Noting the different protein fractions estimated by electrophoresis, the BCG assay showed positive bias and good correlation with α-1 globulin concentrations (r = 0.758; P <.001) (Figure 2) . We observed moderate (r = 0.729; P <.001) and weak correlations (r = 0.585; P <.001) (Figure 3 ) with CRP and α-2 globulin, respectively. We observed no correlation with β-globulin levels (r = 0.120; P = .34) (Figure 4) . Finally, poor negative correlation was demonstrated between the γ-globulin concentration and the appearance of albumin discrepancies between the 2 methods (r = -0.303; P = .01) ( Figure 5 ). The bias between BCG and BCP results appears to be due to the nonspecific reactions of α-globulins (acute phase reactants) in the BCG method.
Figure 1
Average and range for albumin values, as tested by bromocresol green (BCG) and bromocresol purple (BCP) methods.
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The mean (SD) total calcium concentration measured in serum specimens was 2. aCa BCP difference was -0.12 (0.07) (95% CI, -0.13 to -0.10), so there is systematic bias (Figure 6 ).
Using the albumin BCG method to calculate the aCa in all study specimens, there was 1 case of hypocalcaemia (<2.13 mmol/L), 12 cases of hypercalcemia (>2.50 mmol/L), and 87 cases of normocalcemia. Further, using the albumin BCP method, there was 1 case of hypocalcemia, 32 cases of hypercalcemia, and 67 cases of normocalcemia. Thus, the use of one or the other method to determine the albumin level shows a 20% discrepancy: 32 patients were classified as
Figure 2
Correlation of alpha-globulin levels measured via capillary zone electrophoresis (CZE) with the difference between levels of serum albumin measured by bromocresol green (BCG) and bromocresolpurple (BCP) methods.
Figure 3
Correlation of α-2 globulin levels measured via capillary zone electrophoresis (CZE) with the difference between levels of serum albumin measured by bromocresol green (BCG) and bromocresol purple (BCP) methods.
Figure 4
Correlation of β-globulin levels measured via capillary zone electrophoresis (CZE) with the difference between levels of serum albumin measured by bromocresol green (BCG) and bromocresol purple (BCP) methods.
Figure 5
Correlation of γ-globulin levels measured via capillary zone electrophoresis (CZE) with the difference between levels of serum albumin measured by bromocresol green (BCG) and bromocresol purple (BCP) methods. having hypercalcemia when the albumin level was measured by BCP, of which 20 would be considered to have normal results and 12 to have hypercalcemia using the BCG method.
A retrospective study of the aCa levels in our hospitalized patients, as reported in the past year by our emergency and routine laboratories, showed that the percentage of hypocalaemia is greater in our routine laboratory, where the BCG method is used (18.7% vs 6.76%). To overcome the differences between our laboratories in albumin and aCa concentration results, we established a correlation formula between the 2 albumin methods to obtain equivalent results. In the months after the implementation of this equation, these percentages are matched, and the frequency of hypocalcemia in the routine laboratory has lowered substantially.
Discussion
These results demonstrate that the BCG and BCP methods for measuring albumin do not give equivalent results for all specimens. Our study confirms that the BCG method overestimates albumin and is affected by positive interference from acute phase globulins, especially at low concentrations, at which albumin has greater clinical usefulness. The albumin concentrations measured using the BCP method are, on average, more than 5 g per L lower than those obtained using BCG as a colorant. Similar results were obtained in previous studies. [9] [10] [11] We noted that, in certain specimens, albumin BCG concentrations yielded higher results than albumin measured using the serum protein electrophoresis or BCP method. This effect is possibly due to the long read time of the BCG assay.
12 BCG binds to albumin at pH 4.2 to form a complex measured spectrophotometrically at 628 nm. However, at low albumin and high globulin concentrations, the BCG method is not absolutely specific for albumin. α-1 and α-2 globulins contribute to overestimating of the albumin concentration in the BCG assay, with the greatest effects observed for α-1 globulin. Similar results were obtained by Xu et al 13 and Speicher et al. 10 The precise assessment of calcemic status is particularly needed in research and for detecting mild hypo-or hypercalcemia. The choice of method used to measure albumin has a great impact on the calculation of aCa and, therefore, on the classification of patients according to their phosphorus and calcium status. When managing individual patients, this information can lead to inappropriate treatment being given, as well as a failure to meet the needs of the patient. Further, the aCa calculation is sensitive to the analytical variations of calcium, albumin, or protein, and laboratories should use locally derived equations specific to their calcium/ albumin methods and analytical platforms, rather than unvalidated literature derived equations. Our laboratory has not yet made such validation, and the formula used was taken directly from the literature. Performing such validation will be our next step. In the meantime, clinicians should use these estimates as an approximation, when they intuit that total calcium does not reflect the clinical status of the patient.
BCP is a superior method for evaluating serum albumin levels due to its higher specificity compared with BCG. The BCP method yields results that agree closely with those obtained via immunological methods 14, 15 or serum protein electrophoresis. 11 However, this assay is not without problems. Unlike BCG, the BCP method underestimates the albumin concentrations in the serum of patients with renal insufficiency. 14, 15 The underestimation is variable and does not appear to be related to the degree of renal impairment. The interfering substance has not been clearly identified. Similarly, it has been described 16 that the BCP method underestimates albumin concentrations in patients undergoing hemodialysis, particularly in cases of continuous
Figure 6
Bland-Altman analysis for adjusted calcium (aCa) in mmol/L calculated according to the 2 methods available for measuring albumin, BCG and BCP.
ambulatory peritoneal dialysis, owing to the presence of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), an endogenous uremic toxin. 17 There are also difficulties in the standardization and monitoring of albumin BCP assays with nonhuman fluids, due to the fact that BCP-unlike BCG-does not strongly bind to bovine serum albumin, which is often present in calibrators and quality-control materials. The main advantages and disadvantages of both dye-based methods are summarized in Figure 7 .
In conclusion, albumin results from the BCP and BCG methods may result in unacceptable differences and clinical confusion. These discrepancies affect the albumin concentrations and the parameters calculated based on them, such aCa. Both methods have limitations, and it is unlikely that a single albumin methodology will be accepted as the preferred one in the near future. Despite being a long-standing problem in the literature, it is important to remember that this difference in outcomes exists to properly assess patients in their clinical follow-up. Because our laboratory had 2 platforms using these 2 methodologies to quantify albumin, we implemented a correlation equation so that the results were as interchangea- Can use animal based sera for controls and calibrators and controls (low affinity for non-human albumin)
Figure 7
Summary of the main characteristics of the Bromocresol Purple and Bromocresol Green methods
